諾華藥廠 NVS

-
-
-
已收盤:-

淨值比明細

年季
收盤價
權益總計(百萬)
稅後權益報酬率(%)
稅後純益(百萬)
稅後資產報酬率(%)
資產總計(百萬)
2025Q4 137.87 46,549 5.28 2,409 2.21 110,949
2025Q3 128.24 44,752 9.05 3,928 3.71 107,289
2025Q2 121.01 42,054 10.04 4,041 3.96 104,395
2025Q1 111.48 38,452 8.73 3,606 3.57 99,941
2024Q4 97.31 44,126 6.44 2,818 2.74 102,246
2024Q3 115.02 43,441 7.47 3,189 3.17 103,524
2024Q2 106.46 41,902 7.95 3,246 3.38 97,505
2024Q1 96.73 39,756 6.21 2,688 2.77 94,334
2023Q4 100.97 46,750 19.95 8,480 7.98 99,945
2023Q3 101.86 38,245 3.91 1,761 1.57 112,697
2023Q2 100.91 51,931 4.45 2,316 2.08 110,979
2023Q1 92.00 52,142 4.11 2,293 2.00 112,241
2022Q4 90.72 59,423 2.44 1,466 1.24 117,453
2022Q3 76.01 60,898 2.54 1,573 1.30 118,464
2022Q2 84.53 63,006 2.72 1,694 1.37 122,910
2022Q1 87.75 61,704 3.43 2,222 1.73 125,218
2021Q4 87.47 67,822 26.14 16,308 12.89 131,795
2021Q3 81.78 56,937 4.97 2,758 2.25 121,209
2021Q2 91.24 54,128 5.53 2,896 2.36 124,015
2021Q1 85.48 50,589 3.84 2,059 1.62 121,752